Trial of Imatinib (Gleevec®) in Selected Patients With Metastatic Melanoma
This study has been completed.
Sponsor:
Peking University
Collaborator:
Novartis
Information provided by:
Peking University
ClinicalTrials.gov Identifier:
NCT00881049
First received: April 13, 2009
Last updated: January 14, 2011
Last verified: January 2011
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | January 2011 |
| Primary Completion Date: | January 2011 (Final data collection date for primary outcome measure) |